Related Experiment Video
Updated: Jun 19, 2026

Technique for Intranasal Administration of α-Synuclein Aggregates
Published on: November 8, 2024
Beyond RSWA in prodromal α-synuclein disease: Do periodic limb movements signal potential early dopaminergic
Sasikanth Gorantla1, Matteo Cesari2, Raffaele Ferri3
1Department of Neurology/Division of Sleep Medicine, University of California Davis, Sacramento, CA, USA.
Abstract:
Isolated REM sleep behavior disorder (RBD) is an established prodromal biomarker of α-synucleinopathies. However, nearly half of Parkinson's disease patients will not exhibit iRBD or abnormal REM sleep without atonia (RSWA) at disease onset. The SYNONE skin biopsy, which detects phosphorylated α-synuclein in cutaneous nerves, provides objective evidence of pathology even in prodromal or asymptomatic stages. We describe two SYNONE-positive individuals without RSWA and markedly elevated periodic limb movement indices (PLMI >100) and mild restless legs syndrome (RLS). However, another patient with PLMI of 84 tested negative on SYN-One Test. RSWA was assessed using both conventional and automated REM atonia index scoring. To our knowledge, SYNONE-positive and RSWA-negative presentations have not been previously reported. The markedly elevated PLMI may reflect an early sign of dopaminergic dysfunction in the amygdala or spinal cord predominant disease. Longitudinal follow up and further investigation are needed to delineate spatiotemporal progression and clinical evolution.
More Related Videos
12:01Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
05:52Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Neural Regulation
Alterations in Muscle Tone lll
Parkinson Disease l: Introduction
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...